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Abstract
Background: Malaria is still a leading child killer in sub-Saharan Africa. Yet, access to prompt and effective malaria
treatment, a mainstay of any malaria control strategy, is sub-optimal in many settings. Little is known about
obstacles to treatment and community-effectiveness of case-management strategies. This research quantified
treatment seeking behaviour and access to treatment in a highly endemic rural Tanzanian community. The aim
was to provide a better understanding of obstacles to treatment access in order to develop practical and cost-
effective interventions.
Methods: We conducted community-based treatment-seeking surveys including 226 recent fever episodes in
2004 and 2005. The local Demographic Surveillance System provided additional household information. A census
of drug retailers and health facilities provided data on availability and location of treatment sources.
Results: After intensive health education, the biomedical concept of malaria has largely been adopted by the
community. 87.5% (78.2–93.8) of the fever cases in children and 80.7% (68.1–90.0) in adults were treated with
one of the recommended antimalarials (at the time SP, amodiaquine or quinine). However, only 22.5% (13.9–33.2)
of the children and 10.5% (4.0–21.5) of the adults received prompt and appropriate antimalarial treatment. Health
facility attendance increased the odds of receiving an antimalarial (OR = 7.7) but did not have an influence on
correct dosage. The exemption system for under-fives in public health facilities was not functioning and drug
expenditures for children were as high in health facilities as with private retailers.
Conclusion: A clear preference for modern medicine was reflected in the frequent use of antimalarials. Yet,
quality of case-management was far from satisfactory as was the functioning of the exemption mechanism for the
main risk group. Private drug retailers played a central role by complementing existing formal health services in
delivering antimalarial treatment. Health system factors like these need to be tackled urgently in order to translate
the high efficacy of newly introduced artemisinin-based combination therapy (ACT) into equitable community-
effectiveness and health-impact.
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Background
Malaria kills more than one million people annually,
mostly children under five years of age in sub-Saharan
Africa. As part of an integrated approach to malaria con-
trol, the World Health Organization promotes prompt
access to effective treatment for all episodes of malaria [1].
However, it can be safely assumed that of the 2.4 billion
people (2005) living in low-income countries [2], only
few have access to high quality health-care, including
appropriate malaria-treatment [3-5].
Increased attention to the issue of access to treatment is
required in the light of rolling-out highly efficacious
artemisinin-based combination therapy (ACT). Lack of
access is a complex issue that can be better understood
when seen in the context of poverty, vulnerability and
livelihoods [6]. Which obstacles to treatment are relevant
– and should be addressed by interventions – depends to
a large extent on the local setting [3]. As there is no one-
size-fits-all solution, several strategies have been proposed
and tested to improve access to malaria treatment. These
include scaling-up home-based management [7,8],
stronger involvement of the private sector [9,10], improv-
ing case-management in health facilities [11] as well as
integrated approaches [12]. In addition, it is now widely
acknowledged that no malaria-control strategy can be suc-
cessful and sustainable without an increased investment
in the local health system through which the interven-
tions are to be channelled [13-15].
In order to develop targeted and cost-effective interven-
tions, it is essential to add to the knowledge of treatment
rates an understanding of the major obstacles to treatment
access in a particular setting. For Tanzania, the 2004–5
Demographic and Health Survey (DHS) reported 58.2%
antimalarial use in children under 5 years of age with a
recent fever [16]. Yet, how many of these children received
appropriate treatment, in a timely fashion and in the cor-
rect dose – or why others did not receive an antimalarial
drug – is not elaborated upon in DHS surveys.
The studies presented here assessed the impact of local
knowledge of malaria and treatment seeking practices on
access to malaria treatment in a rural Tanzanian commu-
nity. The research was carried out in the frame of a com-
prehensive intervention programme which aims to
improve access to malaria treatment in rural Tanzania
(ACCESS Programme) [17].
Methods
Study setting
Treatment seeking for fever episodes was studied in the
districts of Kilombero and Ulanga, south-eastern Tanza-
nia, in 2004 and 2005. The study area comprised the 25
villages of the local Demographic Surveillance System
(DSS) [18] with a population of 74,200 in 2004, as well
as the town of Ifakara, the district capital of Kilombero
(2001 population census: 45,726 [19]). The area is pre-
dominantly rural and malaria transmission is high and
perennial [20,21]. In 2004, there were 14 health facilities
(9 public, 5 private/mission) in the DSS area, as well as
one private clinic and one district hospital in Ifakara.
Malaria accounted for roughly half of all outpatient visits
in these facilities. Government and private health facilities
in Kilombero were running on a cost-sharing scheme. In
Ulanga, no user fees were charged in government facilities
and a Community Health Fund (CHF) offered a form of
risk-protection for members of the fund. A detailed
description of the study area can be found elsewhere [17].
At the time of the study, the recommended first-line treat-
ment for uncomplicated malaria was SP, the second line
treatment amodiaquine; quinine was recommended as
third-line treatment and for cases of severe malaria [22].
Treatment seeking surveys
To investigate local understanding of malaria and treat-
ment seeking behaviour for recent fever cases, a cross-sec-
tional cultural-epidemiological community survey was
conducted in the DSS area and Ifakara. We took a village-
stratified random sample with the number of households
sampled proportional to the total number of households
in the village. A total of 318 households were drawn from
the registered 16,220 households in the 25 DSS villages.
Only households with at least one child under the age of
five years were eligible.
Sampled households were visited by a DSS interviewer
between May and August 2004, within the schedule of the
routine DSS data collection. In all households in which a
fever episode in the previous 14 days was reported, the
patient or caretaker (if the patient was younger than 12
years) was interviewed. Patients who had not yet recov-
ered were not included, as their options for treatment-
seeking were not yet exhausted. They were instead advised
to seek care from a health facility.
For Ifakara town no up-to-date household list was availa-
ble as a sampling frame. The local administrative structure
was used to establish a list of households and to perform
a two-stage random sampling of 223 households. Every
household in Ifakara was assumed to belong to a ten-cell
(a group which was originally composed of ten house-
holds) and be represented by a ten-cell leader (balozi).
Through visits to local government officials, a compre-
hensive list of all 329 ten-cell leaders in Ifakara was estab-
lished. A random sample of 35 ten-cell leaders was then
visited in order to establish a complete household list for
their ten-cells. Six households per ten-cell were then ran-
domly sampled. A household may only have been missed
if it was not recorded by any ten-cell leader. We tried toBMC Public Health 2008, 8:317 http://www.biomedcentral.com/1471-2458/8/317
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avoid double-listing of households claimed by several
ten-cell leaders by cross-checking the names of the house-
hold heads. Sampled households were visited by two
trained interviewers in May 2004. The same inclusion and
exclusion criteria as in the DSS villages applied.
Spatial data on household locations as well as socio-eco-
nomic status calculations were obtained from the DSS
database, which provided such information for 70% of all
interviewed cases. In order to consider distance to the
nearest point of care as a predictor for treatment access, we
also used geo-spatial data of 16 health facilities and 498
drug selling shops (DSS and Ifakara), collected during a
survey in May – June 2004 [23].
Additional information was derived from a longitudinal
study on treatment seeking behaviour during the main
farming season. This shamba cohort (in Swahili, shamba =
farm) included a random sample of approx. 100 farming
households from 10 randomly selected DSS villages
which were followed-up during the main cultivation
period between December 2004 and August 2005. Every
month, interviews were done with recent fever cases,
applying the same inclusion and exclusion criteria as in
the cross-sectional community survey. A detailed descrip-
tion of this study can be found elsewhere [24].
As the sampling methodologies differed (cross-sectional
vs. longitudinal; general population vs. only farming
households), the two studies may not be equally repre-
sentative of the general population. For the analysis of
people's understanding of malaria it was assumed that
there would be no difference between the two samples
and both datasets were pooled for analysis. However, the
treatment seeking and risk factor analysis for the
shamba cohort study was done separately and presented
elsewhere [24].
In both studies, field-workers used an Explanatory Model
Interview Catalogue (EMIC) for data collection [25]. This
semi-structured interview guide was developed on the
basis of preceding focus-group discussions and further
qualitative research on people's understanding and expe-
rience of malaria [26-28]. EMIC data comprised quantita-
tive information and narratives of reported signs and
symptoms ("patterns of distress"), perceived causes of the
illness, and resulting treatment-seeking behaviour. Apart
from the reported signs and symptoms, the data analysis
took into consideration the name given to the illness by
the respondent (illness label).
Oral informed consent was obtained from all study partic-
ipants prior to the interviews. Ethical clearance for both
studies was granted by the National Institute for Medical
Research of the United Republic of Tanzania (NIMR/HQ/
R.8a/Vol. IX/236, 16th September 2003).
Statistical analysis
Epi Info 6 was used for random sampling procedures.
Data were double entered in Microsoft FoxPro and Micro-
soft Access (Microsoft Corp.), and checked for coding
errors and consistency. Statistical analysis was done with
Intercooled Stata 9 (College Station, Texas, USA). For spa-
tial analyses, MapInfo Professional 7.0 (MapInfo Corp.,
Troy, New York, USA) and ArcView GIS 3.3 (ESRI, Red-
lands, CA, USA) were used.
For cultural-epidemiological data on patterns of distress
(PD) and perceived causes (PC), answers were categorized
and given values according to whether they were reported
spontaneously (value of 2) or upon probing (value of 1).
From these values, means were calculated as a measure-
ment of the prominence of the respective features in the
interviewee's accounts. Similar PD and PC were grouped
for analysis and ranked according to their prominence in
the interviewee's accounts. The Kruskal-Wallis test was
used to test differences in the ranked outcomes between
sub-groups of the sample. Chi2 and Fisher's exact tests
were used to test associations.
Univariate and multivariate logistic models were fitted to
assess the effect of several predictors on prompt and effec-
tive treatment, as defined below. Univariate analysis was
conducted for all possible predictors on which data had
been collected within the frame of the programme. For
the multivariate models, a stepwise backward estimation
was performed with a P > 0.2 significance level for
removal from the model. The likelihood ratio test was
used for significance testing. Both analyses considered vil-
lage vs. town as predictor, but not individual villages. The
sampling strategy of households as described above was
unlikely to have resulted in over-sampling of any of the
villages. We therefore performed aggregate level analyses
which should give unbiased estimates without any village
weighting. In addition, the number of individuals from
each village was very small and hence estimating or allow-
ing for within-village correlation factors in the regression
analysis would be meaningless.
Results
Study sample
In the cross-sectional community survey, 154 recent fever
cases were identified (approximately 28% of all sampled
households). In order to establish a clear distinction
between cases in children and cases in adults, we only
considered the cases aged under five years (80 children)
and over 12 years (57 adults) for our analysis. The shamba
survey added another 29 children under five years and 28BMC Public Health 2008, 8:317 http://www.biomedcentral.com/1471-2458/8/317
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adults over 12 years to the sample. Basic characteristics of
the sample are summarized in Table 1.
Local understanding of febrile illness
The analysis of patterns of distress and perceived causes
considered all children under the age of five years and
adults over 12 years (194 in total).
Based on the illness labels given by the interviewees, fever
cases were classified into three illness categories that
roughly correspond with biomedical malaria. Of the child
cases, 68 (62%) were labelled malaria, 24 (22%) homa (lit-
erally: fever), and 8 (7%) degedege (convulsions, usually
known only as an illness of young children). Of the adult
cases, 54 (64%) were labelled malaria, 26 (31%) homa,
and 2 (2%) degedege. This classification is popular in the
community as has been described in detail in earlier qual-
itative studies from Tanzania [26,28,29]. Homa  and
malaria cases were more relevant for this analysis than the
relatively rare degedege-labelled cases. We included the
degedege cases reported in children, but excluded the two
adult cases. A detailed list of PD and PC variables with cor-
responding prominence values is available as an online
supplement to this paper [see Additional file 1].
Patterns of distress (PD)
In children, fever symptoms and loss of strength were
most prominently mentioned. "Having no strength" was
significantly more prominent in the malaria compared to
the  homa  category (P = 0.023), as was vomiting (P =
0.033). Vomiting was generally more prominent than
diarrhoea. Signs and symptoms related to convulsions
(such as twitching, stiff body, "eyes turn white", kicking of
arm or leg, froth in the mouth, mouth twisted sideways,
as well as delirium, falling down, and being easily startled
or frightened) were most prominent in the degedege cate-
gory. Twitching was significantly more prominent in the
degedege than the malaria (P = 0.029) and the homa cate-
gories (P = 0.022). 68 (62.4%) cases showed at least one
of the aforementioned signs of convulsions. Of these, 44
(61.1%) were labelled malaria, 15 (20.8%) homa, and 7
(9.7%)  degedege, showing clearly that many caretakers
make a link between convulsions and malaria. Respira-
tory symptoms were not very prominent [see Additional
file 2 – Figure A1].
In adults, there was no clear difference in reported PD
between  homa  and  malaria  cases. Symptoms related to
body strength or pain (particularly headache) were at least
as prominent as fever. Nausea and vomiting were more
prominent than diarrhoea. Difficult breathing or cough
Table 1: Sample characteristics
Characteristics 2004 community survey (N = 137) 2005 shamba survey (N = 57)
n Percentage n Percentage
Age group
under 5 years 80 58.4 29 50.9
over 12 years 57 41.6 28 49.1
Sex
Female 76 55.5 25 43.9
Male 61 44.5 32 56.1
Residence
Ulanga DSS villages 53 38.7 31 54.4
Kilombero DSS villages 44 32.1 26 45.6
Ifakara 40 29.2 NA NA
Religion (of caretaker if patient < 12 years)
Muslim 51 37.2 21 36.8
Christian 84 61.3 36 63.2
Years of formal education (of caretaker if patient < 12 years)
Mean (years) 5.4 (95% CI 4.83, 5.89) 6.5 (95% CI 6.01, 6.97)
Median (years) 7 (51.1% of sample) 7 (77.2% of sample)
Household income regular and dependable
Yes 68 49.6 33 57.9
Possibly 18 13.1 3 5.3
Uncertain 13 9.5 7 12.3
No 38 27.7 14 24.6BMC Public Health 2008, 8:317 http://www.biomedcentral.com/1471-2458/8/317
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were less prominent in adults than in children. Convul-
sion-symptoms, such as twitching, were not probed – but
also not mentioned spontaneously [see Additional file 2 –
Figure A1].
Perceived causes (PC)
Fever cases in children were most commonly attributed to
mosquito bites. A "bird or insect called degedege", previ-
ously reported to be seen as a cause of degedege [29] was
not significantly associated with degedege nor with signs of
convulsions. The physical constitution of a child was
rather seen as a cause of homa than malaria (P = 0.023).
Homa rather than malaria was often seen as a "stage of
child growth" (P = 0.033). Cold weather as a cause was
most prominent in the homa, and least prominent in the
malaria category (P = 0.044). Heat as well as cold weather,
was prominently mentioned as a cause of degedege. Super-
natural causes (God, spirits, sorcery, etc.) were rarely men-
tioned. However, of all these, God was mentioned
prominently in the malaria category, just after mosquito
bites [see Additional file 2 – Figure A2].
Also in adults, mosquito bites were mentioned most
prominently. Physical constitution was rather seen as a
cause of homa than malaria. Sanitation or a dirty environ-
ment were more prominent in the malaria category (P =
0.040), while climate-related causes were more promi-
nent in the homa category (P = 0.057). God was the most
prominently mentioned supernatural cause [see Addi-
tional file 2 – Figure A2]. A more detailed description of
local illness concepts can be accessed elsewhere [30].
Help seeking for fever episodes
The analysis of help seeking for a recent febrile illness epi-
sode considered only the 2004 cross-sectional community
survey data.
Immediate help-seeking action
Once a fever episode was recognized, most children and
adults took an antipyretic drug, about 70% of them on the
day of illness onset or the day after. Antimalarial drugs
were less popular as first help seeking action: only 35.0%
(24.7–46.5) of all children and 42.1% (29.1–56.0) of all
adults took an antimalarial on the same or the next day.
62.5% of all caretakers brought their sick child to a health
facility as first action, 45.0% (33.9–56.5) of them within
two days. Significantly fewer adults attended a health
facility as first action (33.3%) and only 21.1% (11.4–
33.9) went there within two days. Cooling one's body
through sponging or a cold bath was done by over 30% of
all children and adults. Traditional medicine or divina-
tion, however, was not common (Figure 1).
Interestingly, even in child-cases labelled malaria, antipy-
retic administration (78.8%, 65.3–88.9) was more fre-
quent as first action than administration of antimalarials
(48.1%, 34.0–62.4). At the same time, the frequency of
antimalarial administration was not significantly different
between the illness labels or between cases with (44.7%,
29.9–59.4) or without convulsions (39.4%, 21.8–57.0).
However, herbal medicine was given significantly more
often to children with degedege than to children with homa
or malaria (P = 0.020). For children, there was a significant
difference between the areas of residence (P = 0.007) with
antimalarials being administered most frequently in
Ulanga DSS (60%) and less frequently in Kilombero DSS
(39%) and Ifakara (18%).
In adult cases, administering antipyretics was the most fre-
quent help seeking action for both homa  and  malaria.
Antimalarials were taken more frequently for malaria than
for homa (P = 0.028). A cold bath or shower was signifi-
cantly more frequent in the malaria (51.4%, 34.0–68.6)
than the homa (10.5%, 1.3–33.1) category (P = 0.003).
Significantly more adults went to a health facility in
Ifakara than in the DSS villages of Kilombero (P = 0.041).
However, no significant difference between the illness
labels was seen in health facility attendance rates.
Sources and appropriateness of malaria treatment
In order to estimate population coverage with prompt and
appropriate malaria treatment ("effective coverage"), key
treatment indicators were assessed, including all reported
treatment steps (Table 2). An almost 100% usage of bio-
medical treatment was noted in adults and children. Anti-
malarial administration to children was common
(88.8%) with the majority receiving quinine (53.8%).
34.9% of the children who received quinine, were given
an injection or infusion. Less than half of the children and
adults received the first-line drug SP. Most of the SP treat-
ments given to children were wrongly dosed. 28.8% (95%
CI 19.2–40.0) of the children and 12.3% (5.1–23.7) of
the adults were treated with more than one product, most
commonly with two (P = 0.022).
Few episodes were treated with an antipyretic only, or
with an antibiotic. Overall, children (76.3%) were more
often brought to a health facility than adults (56.1%).
Children (53.8%) were also more likely to receive their
antimalarial from a health facility than adults (29.8%).
Adults rather opted for non-exclusive (P = 0.040) or exclu-
sive home-management with antimalarials than children.
Generally, drug stores were the most important source for
home-treatment, particularly for adults. However, of the
57 children who were brought to a health facility and
received an antimalarial, 24.6% obtained the drugs from
a source other than the facility.
Timeliness of treatment with an antimalarial was signifi-
cantly better in children than in adults. 76.3% (65.4–BMC Public Health 2008, 8:317 http://www.biomedcentral.com/1471-2458/8/317
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85.1) of the children, but only 56.1% (42.4–69.3) of the
adults received an antimalarial on the day the fever started
or the day after (P = 0.013). When adjusted for age group
(adults vs. children), those who obtained their antimalar-
ial from a health facility were more likely to receive it on
the day the illness started (P = 0.004).
Effective community coverage
Effective community coverage with prompt and appropri-
ate malaria treatment was estimated based on the
reported treatment-seeking behaviour for recent fever epi-
sodes, taking into account the national treatment guide-
lines [22]. The main indicators are shown in Figure 2,
illustrating how dramatically effective coverage is reduced
because of weaknesses in the treatment chain. 87.5%
(78.2–93.8) of the children and 80.7% (68.1–90.0) of the
adults received one of the antimalarials recommended by
the national guidelines (SP, amodiaquine or quinine)
[22](¯). 72.5% (61.4–81.9) of the children and 56.1%
(42.4–69.3) of the adults received these drugs on the day
of onset of the symptoms or the day after (°). 42.5%
(31.5–54.1) of the children and 36.8% (24.4–50.7) of the
adults received the antimalarial not only in time, but also
in the recommended dose (±). Dosage was assessed based
on the patient's or caretaker's accounts. Due to a lack of
detailed information, it was assumed that all injections
were correctly dosed. Most wrong dosages were under-
dosages. If also the reported symptoms are taken into
account, only 22.5% (13.9–33.2) of the children and
10.5% (4.0–21.5) of the adults received timely treatment
with an appropriate and correctly dosed antimalarial. SP
or amodiaquine was considered appropriate for reported
symptoms of uncomplicated malaria, quinine if severe
symptoms (incl. difficult breathing, yellow eyes, convul-
sions, delirium [22,31]) had been reported.
Expenditures for antimalarials
Expenditures for antimalarials of patients exclusively
attending either a health facility or a drug store are pre-
sented in Table 3. Children and adults paid similar prices
in health facilities and in drug stores. Although children
should be treated free of charge in public health facilities,
they paid on average 540 Tanzanian Shillings (TShs) for
antimalarials obtained in health facilities. It was not pos-
sible to distinguish between private and public health
facilities in this analysis. However, there was no difference
between households from villages with either a public or
a private health facility, suggesting that exemption mech-
anisms were not properly implemented. Quinine
(median price TShs 570, interquartile range [IQR] 0–
Immediate help seeking actions taken on the day of illness onset or the day after Figure 1
Immediate help seeking actions taken on the day of illness onset or the day after. Error bars represent 95% confi-
dence intervals.
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1100) was sold frequently and was on average more
expensive than SP (TShs 300, IQR 0–500), contributing
substantially to total drug expenditures.
Factors related to prompt and effective treatment
Three multivariate logistic models were fitted to assess
predictors for the administration of a recommended anti-
Estimated effective coverage of fever treatment modelled based on patients' or caretakers' accounts. Percentages are propor- tions of the study sample with a reported recent fever Figure 2
Estimated effective coverage of fever treatment modelled based on patients' or caretakers' accounts. Percent-
ages are proportions of the study sample with a reported recent fever. ¬ Episode treated. -  Drug administered. ® 
Antimalarial administered. ¯ Recommended antimalarial. ° Recommended antimalarial on same or next day. ± Recom-
mended antimalarial on same/next day, in correct dose.   Recommended antimalarial on same/next day, correct dosage, appro-
priate considering reported symptoms.
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Table 2: Key indicators for help seeking and access to malaria treatment in individuals with fever in the preceding two weeks
Indicator Children
(N = 80)
Adults
(N = 57)
P*
n % (95% CI) TDHS2 n % (95% CI)
Episodes treated 80 100 (95.5–100) 57 100 (93.7–100)
Medications and dosaging:1
Modern medicine 80 100 (95.5–100) 56 98.3 (90.6–100) 0.416∞
Antimalarial drug (AM) 71 88.8 (79.7–94.7) 58.2 (88.6) 47 82.5 (70.1–91.3) 0.293§
- SP 38 47.5 (36.2–59.0) 23.7 (33.8) 25 43.9 (30.7–57.6) 0.673§
- SP correctly dosed 13 16.25 (8.9–26.2) 18 31.6 (19.9–45.2) 0.035§
- amodiaquine 10 12.5 (6.2–21.8) 22.1 (29.3) 5 8.8 (2.9–19.3) 0.491§
- amodiaquine correctly dosed 5 6.3 (2.1–14.0) 3 5.3 (1.1–14.6) 1.000∞
- quinine 43 53.8 (42.2–65.0) 11.9 (23.5) 23 40.4 (27.6–54.2) 0.122§
- other AM 2 2.5 (0.3–8.7) 1 1.8 (0.0–9.4) 1.000∞
Antipyretic only 9 11.3 (5.3–20.3) 9 15.8 (7.5–27.9) 0.438§
Antibiotic 8 10.0 (4.4–18.8) 2 3.5 (0.4–12.1) 0.194∞
Treatment sources:1
Health facility visit 61 76.3 (65.4–85.1) 32 56.1 (42.4–69.3) 0.013§
AM from health facility 43 53.8 (42.2–65.0) 17 29.8 (18.4–43.4) 0.005§
AM not from health facility 28 35.0 (24.7–46.5) 30 52.6 (39.0–66.0) 0.040§
AM from drug store 19 23.8 (15.0–34.6) 26 45.6 (32.4–59.3) 0.007§
AM from general shop 8 10.0 (4.4–18.8) 4 7.0 (2.0–17.0) 0.761∞
AM from home stock (or relative/neighbour) 10 12.5 (6.2–21.8) 6 10.5 (4.0–21.5) 0.723§
Exclusive home-management with AM3 14 17.5 (9.9–27.6) 18 31.6 (19.9–45.2) 0.055§
1One episode may be treated with several drugs from various sources; 2Tanzania Demographic and Health Survey 2004–05 (data for Morogoro 
Region in brackets); 3Episodes never brought to a health facility; * comparison of children and adults; ∞Fisher's exact test; §Chi-square testBMC Public Health 2008, 8:317 http://www.biomedcentral.com/1471-2458/8/317
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malarial, as well as for timely and correctly dosed treat-
ment (Figure 3). Models were fitted once for the DSS only
and once for both the DSS and Ifakara households. Spatial
information and SES were only available for the DSS
households.
Fever cases in DSS households were less likely to receive a
recommended antimalarial if their illness was labelled
homa (fever) (OR = 0.08), they received traditional herbal
medicine as first action (OR = 0.08) or they lived in a
household with a higher total number of people (OR =
0.79). On the other hand, attending a health facility dur-
ing the course of the illness (OR = 7.69) increased the
odds of receiving a recommended antimalarial (Table 4).
When this model was fitted with DSS and Ifakara house-
holds, only the effects of the homa-label and the number
of people in the household were retained. In the univari-
ate analysis, recognising the illness while working in the
fields (shamba) and increased distance to the nearest anti-
malarial provider were also significantly correlated with
less antimalarial administration, while reported diarrhoea
or vomiting significantly increased the odds. Episodes in
DSS households were less likely to receive a recom-
mended antimalarial than those in Ifakara.
The second model assessed predictors for timely treat-
ment (i.e. on the day of illness onset or the day after)
among all those receiving a recommended antimalarial.
None of the plausible predictors was significantly corre-
lated with the outcome with the exception of a higher
number of people in the household, which decreased the
odds of timely malarial treatment (OR = 0.82, 0.69–0.98).
The age of the patient, distance to the nearest provider, or
prior treatment with other medicines were not found to
be significant predictors of the outcome.
Table 3: Median reported expenditure per one dose of antimalarial treatment in health facilities and drug stores (in TShs). US $1 = 
TShs. 1,117 (July 2004)*
Children Adults
n Median expenditure
(IQR)
Range n Median expenditure
(IQR)
Range
Health facility 35 540 (0–1100) 0 to 3000 15 500 (200–700) 0 to 2700
Drug store 16 600 (400–900) 0 to 3600 21 540 (400–800) 60 to 2000
* OANDA currency converter http://www.oanda.com
IQR = Interquartile range
Graphical illustration of treatment indicators assessed in the multivariate models Figure 3
Graphical illustration of treatment indicators assessed in the multivariate models. Circles are roughly proportional 
to the percentage of patients. rAM = recommended antimalarial (SP, amodiaquine, quinine). * includes only SP and amodi-
aquine.
Adult sample (100%)
rAM (81%)
AM* correct
dose (35%)
AM same / 
next day (56%)
(28%)
Adult sample (100%)
rAM (81%)
AM* correct
dose (35%)
AM same / 
next day (56%)
(28%)
    Children sample (100%)
rAM (88%)
AM* correct dose (21%)
AM same / 
next day (73%) (18%)
Children sample (100%)
rAM (88%)
AM* correct dose (21%)
AM same / 
next day (73%) (18%)BMC Public Health 2008, 8:317 http://www.biomedcentral.com/1471-2458/8/317
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The third model assessed predictors for correct dosage
among those receiving SP or amodiaquine. This analysis
did not consider quinine, as it was not possible to estab-
lish the accuracy of the dosage of quinine injections. In
this model, children's odds of receiving the correct dose
was significantly decreased (OR = 0.26, 0.09–0.75) com-
pared to adults. Cases from DSS households were more
likely to receive a correctly dosed drug than those from
Ifakara (OR = 4.44, 1.27–15.51).
Discussion
This paper assessed population coverage with prompt and
effective malaria treatment from the perspective of those
affected. The analysis revealed some important issues for
the development of future malaria control strategies.
However, in order to establish a comprehensive under-
standing of access to health, it may be useful to combine
several approaches, as elaborated by Obrist et al. [6].
Local concepts of malaria will influence successful imple-
mentation of effective case-management [32]. This
research demonstrated clear changes in the understanding
of degedege as compared to historical data. Degedege was
traditionally linked to spirits in the form of a bird or a
moth and mainly herbal treatment would be adminis-
tered by traditional healers [29,33]. Studies done between
1995 and 1997 in the same area found that concepts of
degedege and malaria were fuzzy; while degedege was some-
times seen as a cause of severe malaria, only mild malaria
would be related to mosquito bites [27,34]. Today, fevers
with convulsions were in most cases labelled malaria
rather than degedege. Mosquito bites were usually seen as
the cause for convulsions and degedege. These findings are
Table 4: Univariate and multivariate analyses of predictors for administration of a recommended antimalarial (SP, amodiaquine or 
quinine)
Univariate model* Multivariate model**
Exposure variable Crude OR 95% CI P Adjusted OR 95% CI P
Age group
Adult (> 12 years) 1
Child (< 5 years) 1.67 0.66–4.26 0.280
Total number of people in household 0.85 0.73–0.99 0.041 0.79 0.64–0.97 0.021
Place of illness recognition
Home 1 1
Shamba 0.19 0.07–0.51 0.001 0.29 0.08–1.14 0.076
Diarrhoea or vomiting reported
No 1 1
Yes 5.05 1.73–14.74 0.003 3.24 0.85–12.34 0.084
Signs of severe malaria
No
Yes 2.48 0.78–7.88 0.125 3.60 0.73–17.86 0.117
Illness label (self-defined)
Malaria/degedege 1 1
Homa 0.10 0.04–0.29 0.000 0.08 0.02–0.32 < 0.001
First action: Antipyretic
No 1
Yes 0.61 0.17–2.23 0.451
First action: Traditional medicine
No 1 1
Yes 0.24 0.07–0.81 0.022 0.08 0.01–0.48 0.006
Health facility attendance
No 1 1
Yes 4.46 1.69–11.78 0.003 7.69 1.90–31.11 0.004
Antimalarial provider in village1
No 1
Yes 2.10 0.67–6.59 0.201
Distance to nearest antimalarial provider (km)***/1 0.01 0.00–0.43 0.017
Study area
Ifakara 1
DSS 0.22 0.05–0.98 0.046
* 137 observations; ** 136 observations; *** 76 observations (DSS only); 1 Incl. health facilities, drug stores and general shops stocking antimalarials 
in mid-2004BMC Public Health 2008, 8:317 http://www.biomedcentral.com/1471-2458/8/317
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currently being validated through an in-depth study on
degedege cases. In contrast to degedege, which was consid-
ered a severe and dangerous illness [34], homa ("fever")
was often regarded as a normal stage in child growth or
was attributed to weather conditions. Similar findings
have been reported from other regions of Tanzania [28].
While for homa  and  malaria  different symptoms were
reported in children, this was not the case in adults. It also
appeared that malaria was usually associated with mos-
quitoes whereas homa  was often attributed to other
causes. In earlier studies, homa has been described as a
label for general malaise and aches, sometimes even in the
absence of fever [35,36]. To some extent this may explain
why fever as a symptom was not most prominent in all
homa  cases. Nevertheless, local illness labels may still
influence treatment-seeking behaviour. As a result, those
cases labelled homa were more than 12 times (OR = 0.08)
less likely to receive an antimalarial than cases labelled
malaria or degedege.
An increasing overlap of the popular and biomedical con-
cepts of malaria can be attributed partly to regular and
intensive health education campaigns in the area, from
the national "Mtu ni Afya" (Man is Health) campaign in
the late 1970s [26] to the intensive social marketing of
insecticide-treated nets in the 1990s [27,37]. Neverthe-
less, factual knowledge does not necessarily translate
directly into improved behaviour [34], particularly since
appropriate care-seeking depends on several factors other
than illness understanding.
In contrast to what has been reported from earlier studies
and other areas [38-40], no fever episode remained
untreated. Antimalarial administration was common,
even for cases with convulsions or labelled degedege and
traditional herbal medicine use was rare. This is a major
improvement in treatment seeking when compared to a
household survey carried out in two DSS villages in 1995–
97, which reported 35% of degedege episodes were treated
with herbal medicine and only 2% received an antimalar-
ial [26]. It fits well with the findings of de Savigny et al.
[41] who reported 78.7% of sufferers first use biomedical
care for cases of fatal malaria in Tanzania. Considering
that first treatment with herbal medicine was correlated
with less antimalarial use (OR 0.08), discouraging herbal
treatment may help to increase treatment rates with anti-
malarials.
The frequent usage of antipyretics as first treatment may
partly reflect a decreased availability of antimalarials in
shops [23] and the Tanzanian malaria control policy,
which does not actively promote home-based manage-
ment with antimalarials. Most of the children were
brought to a health facility, which increased the chance of
receiving a recommended antimalarial. Health facility
attendance is generally desirable because other severe
febrile illnesses, such as pneumonia or meningitis, can
not easily be managed at home. Despite high health facil-
ity usage rates, however, the proportion of patients receiv-
ing an appropriate antimalarial timely and correctly dosed
(23% of all children and 11% of all adults) was low and
too far from the 80% target set by the RBM Partnership for
2010 [42]. These figures put into perspective the 51.1%
use of a recommended antimalarial on the same or next
day for Tanzania and 82.7% for Morogoro Region
reported by the DHS [16]. At the same time, the DHS fig-
ures also validate the results of some of our indicators,
except for the rates of quinine use, which were extraordi-
narily high in our study.
Patients, particularly children, who were treated at a
health facility, were not more likely to receive an appro-
priately dosed antimalarial. Reported wrong dosages may
be attributed to poor patient adherence or reporting
errors. Yet, without any doubt, quality of care is a critical
step in assuring appropriate treatment. Merely limiting
antimalarial sales to health facilities and drug stores [23]
has apparently not resulted in an acceptable quality of
case-management. The observed effect of the number of
people in a household on (timely) antimalarial treatment
may be a chance finding or related to intra-household
relations [43]. Yet it may also reflect that in larger families,
child care is often delegated from parents to older siblings
who may not yet know how to handle an illness episode.
In families with more children (or elderly household
members), caretakers may be more busy and have less
time devote to each one.
Children under 5 years of age should be treated free of
charge in (government) health facilities. Yet 25% of the
child episodes seen at a health facility were eventually
treated with a shop-bought antimalarial. One might
expected that commercial sector treatment of childhood
fevers would pose an additional and unnecessary burden
on poor households since in the private sector no exemp-
tion policy applies. Njau et al. reported significantly
higher spending in drug stores (but not general shops)
compared to government health facilities [44]. However,
data from this study suggests that due to a dysfunctional
exemption system drug expenditures did not significantly
differ between health facilities and drug stores. In this sit-
uation, it may even be cheaper to treat a child with shop-
bought drugs. A shorter distance to shops than health
facilities may result in lower secondary costs for time and
transport. This may consequently contribute to higher
facility usage rates and possibly to more use of antimalar-
ials by richer households as reported elsewhere [45]. This
link, however, could not be proven in our study.BMC Public Health 2008, 8:317 http://www.biomedcentral.com/1471-2458/8/317
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Stock-outs of SP, amodiaquine, and quinine, which were
repeatedly observed in the study area [46], may have
forced certain patients to purchase medicines from shops.
The commercial sector therefore plays a pivotal role in
providing life-saving drugs in the case of delivery-failure
of formal health facilities.
The key issues resulting from this research need to be
interpreted in consideration of the research methodology
and the study setting. Case-selection was based on
reported fever rather than lab-confirmed malaria,
acknowledging that due to a lack of diagnostics in most
primary health facilities episodes of fever suggestive of
malaria are treated as such. The Integrated Management of
Childhood Illness (IMCI) algorithms (which are imple-
mented in the study area), as well as the national malaria
treatment guidelines advocate an assessment and treat-
ment based on clinical signs and symptoms if no micros-
copy is available [22]. Very often however, a diagnosis is
based on the patient's or caretaker's reported symptoms
rather than a proper clinical assessment [47,48]. The study
generally relied on patients' or caretakers' accounts which
may result in misreporting of symptoms and treatment
seeking behaviour. However, in real life, it is also the
patient's perceived ill-health that triggers help-seeking
action, rather than a clinical or laboratory diagnosis [4].
When making inferences to other areas one should con-
sider the limited sample size of the studies and the long
history of malaria-control and research activities in the
study area. The latter would suggest that treatment and
coverage rates in the area are likely to be above the Tanza-
nian average.
It is also worth considering that all estimates presented
here did explicitly exclude the aspect of drug efficacy. Yet,
actual efficacy of SP in children in nearby Mlimba village
was reported to be only 65.7% (adequate clinical and par-
asitological response at day 28) [49]. Furthermore, 24 %
of SP tablets and 40 % of quinine sulphate tablets col-
lected in the study area did not meet USP specifications
for the amount of active ingredient and were mostly
under-dosed [17,50]. Adding these factors into an effec-
tiveness-model would result in even lower levels of com-
munity effectiveness than reported in the coverage figures
above.
In the ongoing process of rolling out highly efficacious
artemisinin-based combination therapy (ACT), special
attention will have to be paid to the quality of prescrip-
tion in formal health facilities, the ability and willingness
of patients to comply with the treatment regimen, as well
as to the channels through which these drugs are brought
to the patients. It needs to be closely monitored whether
restricting ACT to the formal health sector will result in
increased community effectiveness (timely administra-
tion of correctly dosed efficacious ACT to all those in
need) or in a decrease in treatment rates without an
improvement in the administered drug regimens.
Conclusion
In the study area, the local understanding of the biomed-
ical concept of malaria has markedly improved after con-
tinuous health education. Further education may have to
focus on how, when and where to treat a febrile illness
instead of reiterating illness concepts. Availability of anti-
malarials has been largely limited to certified providers
and health facility usage was very popular. Nevertheless,
the quality of case-management was far from satisfactory.
Decreased drug efficacy and sub-standard drug quality
may have further decreased effectiveness at community
level. Exemption mechanisms aim to facilitate treatment
access for poor and vulnerable groups but in our setting
they did not seem to be properly implemented. Private
drug retailers played a central role in the provision of
timely malaria treatment, complementing the existing for-
mal health services. All these issues can be attributed to a
health system which is still too weak to deliver a growing
number of increasingly complex health interventions.
Such constraints need to be tackled urgently with an
increased investment in the local health system in order to
translate the high efficacy of newly introduced ACT into
equitable community-effectiveness and health-impact.
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